Demetra celebrates its 10th anniversary
[MILAN, March 16, 2026] – Today is an important milestone for Demetra: the company celebrates ten years since its foundation.
Ten years ago, Demetra began a journey fueled by science, innovation and people. Founded in 2016 through the merger of Tecres and Osartis, together with a strategic partnership in Shanghai, the company was created with a clear ambition: transforming scientific research and technological innovation into solutions capable of advancing orthopaedic and spine care worldwide.
A decade built on science and innovation
Over the past decade, Demetra has grown into an international group built on strong scientific foundations, continuous investment in research and development, and a global network of partners and collaborators.
Innovation supported by scientific evidence has always been at the core of the company’s development. Today, Demetra’s technologies are backed by hundreds of scientific studies, publications and technical reports developed in collaboration with international universities and research centers, reinforcing its commitment to evidence-based innovation and high clinical standards.
Strategic milestones shaping the company
Demetra’s journey has also been defined by important strategic milestones that have strengthened the company’s global presence and technological capabilities.
From regulatory achievements such as MDR certification for Tecres Class III products to the development of Demetra Spine through targeted acquisitions, these steps have expanded the Group’s ecosystem and reinforced its ability to support surgeons, hospitals and healthcare systems with innovative solutions.
Behind these achievements is a global community of teams, partners, distributors and collaborators who have contributed to shaping Demetra’s journey over the past ten years.
As the company celebrates this anniversary, Demetra expresses its gratitude to everyone who has been part of this path and who continues to contribute to its growth and mission: continuing to invest in research, strengthen partnerships and develop technologies designed to improve patients’ lives.
Looking ahead, Demetra remains committed to investing in research, strengthening collaborations and developing technologies designed to improve patients’ lives.
Because the first ten years were only the beginning.
One mission. One voice. We are Demetra.